세계의 유방촬영술 시장(2025-2032년) : 업계 분석, 규모, 점유율, 성장, 동향, 예측

Mammography Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,161,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,458,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,179,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 유방촬영술 시장 규모는 2025년에 32억 4,770만 달러에 달할 것으로 예상되며, 2025-2032년의 예측 기간 동안 9.9%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 62억 8,870만 달러에 달할 것으로 예측되고 있습니다.

유방촬영술은 유방암의 조기 발견 및 진단에 사용되는 특수한 의료용 영상 진단 기술로, 저선량 X선을 이용하여 유선 조직을 가시화합니다., 정부에 의한 검진 이니셔티브의 확대와 세계적인 의료비 증가는 유방촬영술 시장을 형성하는 주요 촉진요인입니다. 정확도 향상, 재현율 저하, 진단 능력 향상을 제공하는 첨단 디지털 및 3D 유방촬영술 기술의 채용이 시장을 견인하고 있습니다.

세계의 유방촬영술 시장은 유방암 이환율의 상승과 조기 진단 및 검진 프로그램의 중시 추세가 주된 요인입니다. 신흥 경제국에서는 헬스케어 인프라가 정비되면서 암 검진에 대한 지원 정책이나 환급 정책과 함께 시장 수요를 한층 더 촉진하고 있습니다. 또한, '유방암의 달'과 같은 정부나 비영리 단체에 의한 홍보 캠페인이 정기적인 유방촬영술 검진의 참여율을 높여 유방촬영술 시스템의 채용 증가로 이어지고 있습니다.

양호한 성장이 예상되지만 유방촬영술 시장은 높은 장비 비용, 농촌 지역 및 저소득 지역의 첨단 영상촬영 시스템에 대한 접근성 제한, 검진 과정에서 발생하는 환자의 불편함 등 여러 문제에 직면해 있습니다. 불필요한 검사와 환자의 우려로 이어지는 위양성 및 과잉진단의 가능성은 여전히 심각한 우려사항입니다. 또한 일부 지역에서는 숙련된 방사선과 의사와 방사선사가 부족하여 대규모 검진 프로그램의 효과적인 실시를 저해할 가능성이 있습니다.

유방촬영술 시장은 AI를 활용한 이미지 해석, 휴대형 또는 이동형 유방촬영장치, 그리고 원격 진찰과 원격 유방촬영을 가능하게 하는 클라우드 기반 진단 플랫폼에 대한 지속적인 투자를 통해 강력한 성장 기회를 창출하고 있습니다. 디지털 솔루션과의 통합으로 더욱 더 맞춤화되고 효율적인 유방암 검사가 가능해지고 있습니다. 또한 왕진 활동과 민관 파트너십을 통해 서비스 자원이 부족한 지역으로 시장이 확대되면서 시장 침투를 가속화할 것으로 예상됩니다.

이 보고서는 세계 유방촬영술 시장을 조사했으며, 제품 유형별, 기술별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 시장 리스크와 동향 평가

• 리스크 평가
• 시장에 영향을 미치는 주요 동향
• 처방과 제품 개발 동향

제4장 시장 배경과 기초 데이터 포인트

• 세계의 유방촬영술 시장
• 유방촬영술 시장의 기회 평가
• 시장 시나리오 예측
• 투자 실현 가능성 분석
• 예측 요인 - 관련성과 영향
• 시장 역학

제5장 성공의 핵심 요소

제6장 세계의 유방촬영술 시장 전망(2019-2032년)

• 과거 시장 분석(2019-2024년)
• 현재 및 미래 시장 예측(2025-2032년)
• 전년 대비 성장 동향 분석

제7장 세계의 유방촬영술 시장 규모 전망(2019-2032년)

• 과거 시장 규모(100만 달러) 분석(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측(2025-2032년)

제8장 세계의 유방촬영술 시장 전망(2019-2032년), 제품 유형별

• 소개/주요 조사 결과
• 과거 시장 규모(100만 달러) 분석, 제품 유형별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 제품 유형별(2025-2032년)
  • 필름 스크린 시스템
  • 디지털 시스템
  • 아날로그 시스템
  • 생검 시스템
  • 3D 시스템
• 시장의 매력 분석, 제품 유형별

제9장 세계의 유방촬영술 시장 전망(2019-2032년), 기술별

• 소개/주요 조사 결과
• 과거 시장 규모(100만 달러) 분석, 기술별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 기술별(2025-2032년)
  • 유방 단층촬영술
  • CAD
  • 디지털
• 시장의 매력 분석, 기술별

제10장 세계의 유방촬영술 시장 전망(2019-2032년), 지역별

• 소개
• 과거 시장 규모(100만 달러) 분석, 지역별(2019-2024년)
• 현재 및 미래 시장 규모(100만 달러) 예측, 지역별(2025-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
• 시장의 매력 분석, 지역별

제11장 북미 유방촬영술 시장 전망(2019-2032년)

제12장 라틴아메리카의 유방촬영술 시장 전망(2019-2032년)

제13장 유럽 유방촬영술 시장 전망(2019-2032년)

제14장 아시아태평양의 유방촬영술 시장 전망(2019-2032년)

제15장 중동 및 아프리카 유방촬영술 시장 전망(2019-2032년)

제16장 주요국의 유방촬영술 시장 전망(2019-2032년)

• 소개
• 미국
• 캐나다
• 멕시코
• 브라질
• 독일
• 프랑스
• 이탈리아
• 베네룩스
• 영국
• 북유럽 국가
• 중국
• 일본
• 한국
• GCC 국가
• 남아프리카
• 튀르키예

제17장 시장 구조 분석

제18장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • FUJIFILM HOLDINGS CORPORATION
  • HOLOGIC INC.
  • KONINKLIJKE PHILIPS NV
  • SIEMENS HEALTHCARE GMBH(SIEMENS HEALTHINEERS)
  • CANON MEDICAL SYSTEMS CORPORATION

제19장 전제와 약어 설명

제20장 조사 방법

CSM

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for mammography. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global mammography market from 2025 to 2032.

Key Insights:

• Mammography Market Size (2025E): USD 3,247.7 Million
• Projected Market Value (2032F): USD 6,288.7 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 9.9%

Mammography Market - Report Scope:

Mammography is a specialized medical imaging technique used for the early detection and diagnosis of breast cancer, employing low-dose X-rays to visualize breast tissue. The mammography market includes a wide range of products such as film-screen mammography systems, digital mammography systems, 3D mammography (tomosynthesis), and breast biopsy devices. Increasing awareness of breast cancer, growing government screening initiatives, and rising healthcare expenditures globally are key drivers shaping the mammography landscape. The adoption of advanced digital and 3D mammography technologies, which offer enhanced accuracy, lower recall rates, and improved diagnostic capabilities, is propelling the market forward. The market serves hospitals, diagnostic centers, breast care clinics, and mobile health units.

Market Growth Drivers:

The global mammography market is primarily driven by the rising prevalence of breast cancer and the growing emphasis on early diagnosis and screening programs. Technological advancements, such as digital breast tomosynthesis (DBT), artificial intelligence (AI)-based diagnostic tools, and contrast-enhanced mammography, are significantly improving image quality, diagnostic precision, and workflow efficiency. Increasing healthcare infrastructure development in emerging economies, along with supportive policies and reimbursement frameworks for cancer screening, further fuels market demand. Additionally, awareness campaigns by governments and non-profit organizations, such as Breast Cancer Awareness Month, have led to increased patient participation in regular mammography screenings, boosting the adoption of mammography systems.

Market Restraints:

Despite favorable growth prospects, the mammography market faces several challenges, including high equipment costs, limited access to advanced imaging systems in rural and low-income regions, and patient discomfort during the screening process. The risk of false positives and overdiagnosis, leading to unnecessary biopsies and patient anxiety, remains a critical concern in conventional mammography. Furthermore, a shortage of trained radiologists and technicians in certain geographies may hinder effective implementation of large-scale screening programs. Regulatory complexities and the need for periodic product upgrades also add to the operational burdens for healthcare facilities and manufacturers alike.

Market Opportunities:

The mammography market presents robust growth opportunities through continued investment in AI-driven imaging analysis, portable and mobile mammography units, and cloud-based diagnostic platforms that enable remote consultations and telemammography. The integration of digital health solutions and data analytics facilitates more personalized and efficient breast cancer screening approaches. Expansion into underserved regions through mobile screening initiatives and public-private partnerships is also expected to accelerate market penetration. Moreover, the development of pain-free and radiation-free imaging alternatives under research and innovation pipelines holds potential for future market transformation.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the mammography market globally?
• Which mammography technologies are gaining traction across different clinical settings?
• How are technological advancements improving diagnostic accuracy and patient comfort?
• Who are the leading players in the mammography market, and what strategies are they using to enhance market share?
• What are the emerging trends and growth prospects in the global mammography market?

Competitive Intelligence and Business Strategy:

Leading players in the global mammography market, including Hologic, Inc., GE Healthcare, Siemens Healthineers, and FUJIFILM Holdings Corporation, are focusing on product innovation, digital integration, and strategic collaborations to strengthen their market positions. These companies are investing in AI-powered diagnostic tools, 3D mammography systems, and cloud-based platforms to provide efficient and accurate breast cancer screening solutions. Partnerships with healthcare providers, governments, and non-governmental organizations are enabling broader outreach through mobile screening programs and subsidized diagnostic services. Emphasis on patient-centric product development, regulatory approvals, and global expansion further defines the competitive strategies of key market players.

Key Companies Profiled:

• Hologic Inc.
• Analogic Corporation
• Canon Medical Systems Corporation
• Fujifilm Corporation
• Siemens Healthcare
• Toshiba Medical Systems
• GE Healthcare
• Metaltronica
• Koninklijke Philips NV
• PLANMED OY

Market Segments Covered in Mammography Industry Analysis

By Product Type

• Film Screen Systems
• Digital Systems
• Analog Systems
• Biopsy Systems
• 3D Systems

By Technology

• Breast Tomosynthesis
• CAD
• Digital

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Summary of Statistics
• 1.3. Key Market Characteristics & Attributes
• 1.4. Fact.MR Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

• 3.1. Risk Assessment
  • 3.1.1. COVID-19 Crisis and Impact on Mammography Demand
  • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
  • 3.1.3. Impact on Market Value (US$ Mn)
  • 3.1.4. Assessment by Key Countries
  • 3.1.5. Assessment by Key Market Segments
  • 3.1.6. Action Points and Recommendation for Suppliers
• 3.2. Key Trends Impacting the Market
• 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

• 4.1. Global Mammography Market (US$ Mn)
• 4.2. Mammography Market Opportunity Assessment (US$ Mn)
  • 4.2.1. Total Available Market
  • 4.2.2. Serviceable Addressable Market
  • 4.2.3. Serviceable Obtainable Market
• 4.3. Market Scenario Forecast
  • 4.3.1. Demand in optimistic Scenario
  • 4.3.2. Demand in Likely Scenario
  • 4.3.3. Demand in Conservative Scenario
• 4.4. Investment Feasibility Analysis
  • 4.4.1. Investment in Established Markets
    • 4.4.1.1. In Short Term
    • 4.4.1.2. In Long Term
  • 4.4.2. Investment in Emerging Markets
    • 4.4.2.1. In Short Term
    • 4.4.2.2. In Long Term
• 4.5. Forecast Factors - Relevance & Impact
  • 4.5.1. Top Companies Historical Growth
  • 4.5.2. Global Mammography Market Growth
  • 4.5.3. Mammography Adoption Rate, By Country
• 4.6. Market Dynamics
  • 4.6.1. Market Driving Factors and Impact Assessment
  • 4.6.2. Prominent Market Challenges and Impact Assessment
  • 4.6.3. Mammography Market Opportunities
  • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

• 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
• 5.2. Banking on with Segments High Incremental Opportunity
• 5.3. Peer Benchmarking

6. Global Mammography Market Outlook, 2019-2032

• 6.1. Historical Market Analysis, 2019-2024
• 6.2. Current and Future Market Projections, 2025-2032
• 6.3. Y-o-Y Growth Trend Analysis

7. Global Mammography Market Value Outlook, 2019-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammography Market Outlook, 2019-2032, By Product Type

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2024
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2025-2032
  • 8.3.1. Film Screen System
  • 8.3.2. Digital Systems
  • 8.3.3. Analog Systems
  • 8.3.4. Biopsy Systems
  • 8.3.5. 3D Systems
• 8.4. Market Attractiveness Analysis By Product Type

9. Global Mammography Market Outlook, 2019-2032, By Technology

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2019-2024
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
  • 9.3.1. Breast Tomosynthesis
  • 9.3.2. CAD
  • 9.3.3. Digital
• 9.4. Market Attractiveness Analysis By Technology

10. Global Mammography Market Outlook, 2019-2032, By Region

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
• 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2025-2032
  • 10.3.1. North America
  • 10.3.2. Latin America
  • 10.3.3. Europe
  • 10.3.4. Asia Pacific
  • 10.3.5. Middle East and Africa (MEA)
• 10.4. Market Attractiveness Analysis By Region

11. North America Mammography Market Outlook, 2019-2032

• 11.1. Introduction
• 11.2. Pricing Analysis
• 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2025-2032
  • 11.4.1. By Country
    • 11.4.1.1. U.S.
    • 11.4.1.2. Canada
    • 11.4.1.3. Rest of North America
  • 11.4.2. By Product Type
  • 11.4.3. By Technology
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Country
  • 11.5.2. By Product Type
  • 11.5.3. By Technology

12. Latin America Mammography Market Outlook, 2019-2032

• 12.1. Introduction
• 12.2. Pricing Analysis
• 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2025-2032
  • 12.4.1. By Country
    • 12.4.1.1. Brazil
    • 12.4.1.2. Mexico
    • 12.4.1.3. Rest of Latin America
  • 12.4.2. By Product Type
  • 12.4.3. By Technology
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Country
  • 12.5.2. By Product Type
  • 12.5.3. By Technology

13. Europe Mammography Market Outlook, 2019-2032

• 13.1. Introduction
• 13.2. Pricing Analysis
• 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2025-2032
  • 13.4.1. By Country
    • 13.4.1.1. Germany
    • 13.4.1.2. France
    • 13.4.1.3. U.K.
    • 13.4.1.4. Italy
    • 13.4.1.5. Benelux
    • 13.4.1.6. Nordic Countries
    • 13.4.1.7. Rest of Europe
  • 13.4.2. By Product Type
  • 13.4.3. By Technology
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Country
  • 13.5.2. By Product Type
  • 13.5.3. By Technology

14. Asia Pacific Mammography Market Outlook, 2019-2032

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2025-2032
  • 14.4.1. By Country
    • 14.4.1.1. China
    • 14.4.1.2. Japan
    • 14.4.1.3. South Korea
    • 14.4.1.4. Rest of Asia Pacific
  • 14.4.2. By Product Type
  • 14.4.3. By Technology
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Product Type
  • 14.5.3. By Technology

15. Middle East and Africa Mammography Market Outlook, 2019-2032

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
• 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2025-2032
  • 15.4.1. By Country
    • 15.4.1.1. GCC Countries
    • 15.4.1.2. South Africa
    • 15.4.1.3. Turkey
    • 15.4.1.4. Rest of Middle East and Africa
  • 15.4.2. By Product Type
  • 15.4.3. By Technology
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Product Type
  • 15.5.3. By Technology

16. Key Countries Mammography Market Outlook, 2019-2032

• 16.1. Introduction
  • 16.1.1. Market Value Proportion Analysis, By Key Countries
  • 16.1.2. Global Vs. Country Growth Comparison
• 16.2. US Mammography Market Analysis
  • 16.2.1. Value Proportion Analysis by Market Taxonomy
  • 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.2.2.1. By Product Type
    • 16.2.2.2. By Technology
• 16.3. Canada Mammography Market Analysis
  • 16.3.1. Value Proportion Analysis by Market Taxonomy
  • 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.3.2.1. By Product Type
    • 16.3.2.2. By Technology
• 16.4. Mexico Mammography Market Analysis
  • 16.4.1. Value Proportion Analysis by Market Taxonomy
  • 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.4.2.1. By Product Type
    • 16.4.2.2. By Technology
• 16.5. Brazil Mammography Market Analysis
  • 16.5.1. Value Proportion Analysis by Market Taxonomy
  • 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.5.2.1. By Product Type
    • 16.5.2.2. By Technology
• 16.6. Germany Mammography Market Analysis
  • 16.6.1. Value Proportion Analysis by Market Taxonomy
  • 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.6.2.1. By Product Type
    • 16.6.2.2. By Technology
• 16.7. France Mammography Market Analysis
  • 16.7.1. Value Proportion Analysis by Market Taxonomy
  • 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.7.2.1. By Product Type
    • 16.7.2.2. By Technology
• 16.8. Italy Mammography Market Analysis
  • 16.8.1. Value Proportion Analysis by Market Taxonomy
  • 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.8.2.1. By Product Type
    • 16.8.2.2. By Technology
• 16.9. BENELUX Mammography Market Analysis
  • 16.9.1. Value Proportion Analysis by Market Taxonomy
  • 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.9.2.1. By Product Type
    • 16.9.2.2. By Technology
• 16.10. UK Mammography Market Analysis
  • 16.10.1. Value Proportion Analysis by Market Taxonomy
  • 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.10.2.1. By Product Type
    • 16.10.2.2. By Technology
• 16.11. Nordic Countries Mammography Market Analysis
  • 16.11.1. Value Proportion Analysis by Market Taxonomy
  • 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.11.2.1. By Product Type
    • 16.11.2.2. By Technology
• 16.12. China Mammography Market Analysis
  • 16.12.1. Value Proportion Analysis by Market Taxonomy
  • 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.12.2.1. By Product Type
    • 16.12.2.2. By Technology
• 16.13. Japan Mammography Market Analysis
  • 16.13.1. Value Proportion Analysis by Market Taxonomy
  • 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.13.2.1. By Product Type
    • 16.13.2.2. By Technology
• 16.14. South Korea Mammography Market Analysis
  • 16.14.1. Value Proportion Analysis by Market Taxonomy
  • 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.14.2.1. By Product Type
    • 16.14.2.2. By Technology
• 16.15. GCC Countries Mammography Market Analysis
  • 16.15.1. Value Proportion Analysis by Market Taxonomy
  • 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.15.2.1. By Product Type
    • 16.15.2.2. By Technology
• 16.16. South Africa Mammography Market Analysis
  • 16.16.1. Value Proportion Analysis by Market Taxonomy
  • 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.16.2.1. By Product Type
    • 16.16.2.2. By Technology
• 16.17. Turkey Mammography Market Analysis
  • 16.17.1. Value Proportion Analysis by Market Taxonomy
  • 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
    • 16.17.2.1. By Product Type
    • 16.17.2.2. By Technology
  • 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

• 17.1. Market Analysis by Tier of Companies
• 17.2. Market Concentration
• 17.3. Market Share Analysis of Top Players
• 17.4. Market Presence Analysis
  • 17.4.1. By Regional footprint of Players
  • 17.4.2. Product footprint by Players

18. Competition Analysis

• 18.1. Competition Dashboard
• 18.2. Competition Benchmarking
• 18.3. Competition Deep Dive
  • 18.3.1. FUJIFILM HOLDINGS CORPORATION
    • 18.3.1.1. Company Overview
    • 18.3.1.2. Product Portfolio
    • 18.3.1.3. Key Strategies
  • 18.3.2. HOLOGIC INC.
    • 18.3.2.1. Company Overview
    • 18.3.2.2. Product Portfolio
    • 18.3.2.3. Key Strategies
  • 18.3.3. KONINKLIJKE PHILIPS N.V.
    • 18.3.3.1. Company Overview
    • 18.3.3.2. Product Portfolio
    • 18.3.3.3. Key Strategies
  • 18.3.4. SIEMENS HEALTHCARE GMBH (SIEMENS HEALTHINEERS)
    • 18.3.4.1. Company Overview
    • 18.3.4.2. Product Portfolio
    • 18.3.4.3. Key Strategies
  • 18.3.5. CANON MEDICAL SYSTEMS CORPORATION
    • 18.3.5.1. Company Overview
    • 18.3.5.2. Product Portfolio
    • 18.3.5.3. Key Strategies

19. Assumptions and Acronyms Used

20. Research Methodology

관련자료